Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma

Author:

Ye Qing1,Xu-Monette Zijun Y.1,Tzankov Alexandar2,Deng Lijuan1,Wang Xiaoxiao1,Manyam Ganiraju C.3,Visco Carlo4,Montes-Moreno Santiago5,Zhang Li3,Dybkær Karen6,Chiu April7,Orazi Attilio8,Zu Youli9,Bhagat Govind10,Richards Kristy L.11,Hsi Eric D.12,Choi William W.L.13,van Krieken J. Han14,Huh Jooryung15,Ponzoni Maurilio16,Ferreri Andrés J.M.16,Parsons Ben M.17,Møller Michael B.18,Piris Miguel A.5,Winter Jane N.19,Medeiros L. Jeffrey1,Hu Shimin1,Young Ken H.120

Affiliation:

1. Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

2. University Hospital, Basel, Switzerland

3. Department of Computational Biology and Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

4. San Bortolo Hospital, Vicenza, Italy

5. Hospital Universitario Marques de Valdecilla, Santander, Spain

6. Aalborg University Hospital, Aalborg, Denmark

7. Memorial Sloan-Kettering Cancer Center, New York, New York, USA

8. Weill Medical College of Cornell University, New York, New York, USA

9. Houston Methodist Hospital, Houston, Texas, USA

10. Columbia University Medical Center and New York Presbyterian Hospital, New York, New York, USA

11. University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA

12. Cleveland Clinic, Cleveland, Ohio, USA

13. University of Hong Kong Li Ka Shing Faculty of Medicine, Hong Kong, China

14. Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands

15. Asan Medical Center, Ulsan University College of Medicine, Seoul, Korea

16. San Raffaele H. Scientific Institute, Milan, Italy

17. Gundersen Lutheran Health System, La Crosse, Wisconsin, USA

18. Odense University Hospital, Odense, Denmark

19. Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA

20. The University of Texas School of Medicine, Graduate School of Biomedical Sciences, Houston, Texas, USA

Publisher

Impact Journals, LLC

Subject

Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3